J Wouter Jukema Selected Research

Unstable Angina

7/2003

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Wouter Jukema Research Topics

Disease

3	Coronary Disease (Coronary Heart Disease) 01/2017 - 02/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2010 - 05/2004
2	ST Elevation Myocardial Infarction 08/2017 - 02/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 02/2014
2	Hemorrhage 01/2016 - 02/2012
2	Type 2 Diabetes Mellitus (MODY) 06/2012 - 12/2010
2	Thrombosis (Thrombus) 05/2010 - 07/2003
1	Acute Coronary Syndrome 10/2022
1	Rheumatoid Arthritis 08/2017
1	Vascular Diseases (Vascular Disease) 01/2017
1	Stroke (Strokes) 01/2017
1	Myocardial Infarction 01/2017
1	Chest Pain (Chest Pains) 02/2016
1	von Willebrand Diseases (von Willebrand's Disease) 01/2016
1	Hyperlipidemias (Hyperlipidemia) 06/2012
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 06/2012
1	Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia) 06/2012
1	Hypertriglyceridemia 06/2012
1	Insulin Resistance 06/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2012
1	Pancreatitis 06/2012
1	Diabetes Mellitus 06/2012
1	Obesity 06/2012
1	Hypotension (Low Blood Pressure) 02/2011
1	Neoplasms (Cancer) 02/2011
1	Abdominal Obesity 02/2011
1	Hypertriglyceridemic Waist 12/2010
1	Coronary Stenosis (Coronary Artery Stenosis) 06/2009
1	Ischemia 06/2009
1	Inflammation (Inflammations) 10/2006
1	Atherosclerosis 05/2004
1	Unstable Angina 07/2003
1	Atherosclerotic Plaque (Atheroma) 01/2003

Drug/Important Bio-Agent (IBA)

3	Pravastatin (Pravachol)FDA LinkGeneric 01/2017 - 05/2004
3	LipidsIBA 01/2017 - 12/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 05/2004
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017 - 02/2011
2	CalciumIBA 02/2016 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 02/2011 - 12/2010
1	dalcetrapibIBA 10/2022
1	Anti-Citrullinated Protein AntibodiesIBA 08/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	EnzymesIBA 01/2017
1	darapladibIBA 01/2017
1	von Willebrand FactorIBA 01/2016
1	HomocysteineIBA 02/2014
1	Fibric Acids (Fibrates)IBA 06/2012
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2012
1	ApolipoproteinsIBA 06/2012
1	Fish OilsIBA 06/2012
1	oxidized low density lipoproteinIBA 06/2012
1	Prasugrel Hydrochloride FDA Link 02/2012
1	Clopidogrel (Plavix)FDA Link 02/2012
1	TicagrelorIBA 02/2012
1	AdiponectinIBA 02/2011
1	C-Reactive ProteinIBA 02/2011
1	Fibrinogen (Factor I)FDA Link 02/2011
1	Lipoproteins (Lipoprotein)IBA 02/2011
1	HDL CholesterolIBA 02/2011
1	Peroxidase (Myeloperoxidase)IBA 02/2011
1	Secretory Phospholipases A2IBA 02/2011
1	Triglycerides (Triacylglycerol)IBA 12/2010
1	MetalsIBA 05/2010
1	Phenobarbital (Luminal)FDA Link 06/2009
1	DNA (Deoxyribonucleic Acid)IBA 05/2004
1	endotoxin receptorIBA 05/2004
1	AntigensIBA 07/2003
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 07/2003
1	atorvastatin drug combination amlodipine FDA Link 01/2003
1	Apolipoproteins E (ApoE)IBA 01/2003

Therapy/Procedure

3	Therapeutics 10/2022 - 02/2012
1	Secondary Prevention 01/2017
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2011
1	Drug-Eluting Stents 05/2010
1	Stents 05/2010
1	Percutaneous Coronary Intervention 10/2006